Document:

Exhibit 10.1

Exhibit 10.1
CONSULTING AGREEMENT

THIS CONSULTING AGREEMENT is made and entered into as of the 19th day of January, 2005 by and
between JAMES D. YANCEY, an individual resident of the State of Georgia (“Yancey”), and SYNOVUS
FINANCIAL CORP., a business corporation organized and existing under the laws of the State of
Georgia (“Synovus”).

W I T N E S S E T H :

WHEREAS, Yancey has decided to retire from his position as an executive employee of Synovus as
of December 31, 2004;

WHEREAS, Synovus desires to provide for the retention by Synovus of Yancey’s services as a
consultant after such retirement; and

WHEREAS, Yancey desires to serve Synovus as a consultant under the terms and conditions of
this agreement;

NOW THEREFORE, for and in consideration of the mutual covenants and agreements set forth
herein, Yancey and Synovus, intending to be legally bound, do hereby agree as follows:

Section I.

CONSULTING RELATIONSHIP

Synovus hereby engages Yancey, and Yancey hereby accepts such engagement, to perform such
consulting and advisory services as may be requested from time to time by the Chief Executive
Officer of Synovus. In providing such services, Yancey shall not be required to adhere to a fixed
schedule or to work for a certain number of hours. Yancey shall not be required to devote a major
or substantial part of his time to such services. The Chief Executive Officer of Synovus may
establish the results to be accomplished in connection with consulting and advisory services
requested from Yancey, but Yancey shall control the means and methods of accomplishing the results,
Yancey may establish his own work schedule and shall be free at all times to arrange the time and
manner of performance of consulting and advisory services requested from him.

Section II.

TERM OF ENGAGEMENT

Yancey’s engagement under this Consulting Agreement shall commence as of January 19, 2005, and
end on December 31, 2005.

Section III.

COMPENSATION

3.1 In consideration of the consulting services to be rendered by Yancey hereunder, and in
consideration of the covenants and agreements of Yancey herein contained, Synovus hereby agrees to
pay to Yancey, for each month (or partial month) during the term of this Consulting Agreement, a
consulting fee of $27,487.33. Payments made hereunder shall be paid to Yancey on the last day of
each month during the term hereof.

3.2 During the term of this Agreement, Yancey shall be entitled to the personal use of Synovus
aircraft in accordance with the Synovus Personal Use of Company Aircraft policy (“Policy”), as such
Policy may be amended from time to time. A copy of the current version of the Policy, as it exists
on the date of this Agreement, is attached as Exhibit “A” and made a part hereof by this reference.

3.3 Yancey acknowledges that he is an independent contractor for all purposes. Yancey agrees
to treat all payments made to him hereunder as payments received by an independent contractor for
all tax purposes and to pay any and all taxes payable in connection with his engagement hereunder,
including, without limitation, all applicable income and self employment taxes.

3.4 The obligations of Synovus under Sections 3.1 and 3.2 hereof shall terminate if, during
Yancey’s engagement hereunder, Yancey, unless acting with the prior written consent of the Board of
Directors of Synovus, provides services of any sort to, or assists in any way, with or without
compensation, any entity engaged in activities permissible for a financial holding company
(including, but not limited to, a bank or bank holding company, a savings and loan association or a
brokerage concern) or any enterprise engaged in the business of electronic payment processing,
other than Synovus and its affiliates.

Section IV.

BOARD POSITIONS

4.1 Yancey agrees to continue to serve as Chairman of the Board of Directors of Synovus and as
Chairman of the Board of Directors of Columbus Bank and Trust Company (“CB&T”). Synovus and Yancey
agree to review Yancey’s Board of Director positions and memberships on a periodic basis during the
term of this Agreement.

Section V.

DEATH OR DISABILITY

Yancey’s engagement under this Consulting Agreement shall terminate upon Yancey’s death or
total and permanent disability. For purposes of this Consulting Agreement, the term “total and
permanent disability” shall mean the substantial physical or mental inability of Yancey to fulfill
his duties under this Consulting Agreement as certified to in writing by two (2) competent
physicians practicing in Columbus, Georgia, one of whom shall be selected by Synovus’ Board of
Directors and the other of whom shall be selected by Yancey or his duly appointed guardian or legal
representative.

Section VI.

NONDISCLOSURE

6.1 Yancey shall hold in confidence at all times after the date hereof all Trade Secrets, and
shall not disclose, publish or make use at any time after the date hereof the Trade Secrets without
the prior written consent of Synovus. Yancey also agrees that during the term of his engagement
under this Consulting Agreement and for a period of two (2) years following the termination
thereof, Yancey will hold in confidence all Confidential Information and will not disclose, publish
or make use of Confidential Information without the prior written consent of Synovus.

       6.2  For the purposes of this Consulting Agreement, “Confidential Information” shall mean any
data or information, other than Trade Secrets, which is valuable to any of Synovus or any of its
affiliates (hereinafter the “Synovus Companies”) and not generally known to competitors of the
Synovus Companies. “Trade Secrets” shall mean information belonging to or hereafter acquired by
any of the Synovus Companies, including, but not limited to, technical or nontechnical data, a
formula, pattern, compilation, program, device, method, technique, drawing, process, financial
data, financial plan, product plan, list of actual or potential customers or suppliers, or other
information similar to any of the foregoing, which derives economic value, actual or potential,
from not being generally known to, and not being readily ascertainable by proper means by, other
persons who can derive economic value from its disclosure or use. For purposes of this Consulting
Agreement, the term Trade Secrets shall not include information that Yancey can show by competent
proof (i) was known to Yancey and reduced to writing prior to disclosure by any of the Synovus
Companies (but only if Yancey promptly notifies Synovus of his prior knowledge); (ii) was generally
known to the public at the time any of the Synovus Companies disclosed the information to Yancey,
(iii) became generally known to the public after disclosure by any of the Synovus Companies through
no act or omission of Yancey; or (iv) was disclosed to Yancey by a third party having a bona fide
right both to possess the information and to disclose the information to Yancey.

Section VII.

MISCELLANEOUS

7.1 Governing Law. This Consulting Agreement shall be governed by and interpreted
under the laws of the State of Georgia without regard to its conflict or choice of law provisions.

7.2 Notices. All notices or other communications required or permitted hereunder or
necessary and convenient in connection herewith shall be in writing and delivered in person or by
express delivery service or postage prepaid first class mail, return receipt requested, to the
following addresses:

If to Yancey:

James D. Yancey

6049 Round Hill Court

Columbus, Georgia 31904

If to Synovus:

Synovus Financial Corp.

P.O. Box 120

Columbus, Georgia 31902

or to such other addresses as Yancey or Synovus may designate by notice to the other parties hereto
in the manner set forth in this Section VII.

7.3 Entire Agreement. This Consulting Agreement sets forth the entire agreement of
the parties hereto with respect to the subject matter hereof and may not be changed or amended
except upon written amendment executed by the parties hereto.

7.4 Assignment. All of the terms and provisions of this Consulting Agreement shall be
binding upon and inure to the benefit of and be enforceable by the respective heirs,
representatives, successors and assigns of the parties hereto, except that the duties and
responsibilities of Yancey hereunder shall not be assignable in whole or in part by Yancey.

7.5 Counterparts. This Consulting Agreement may be executed in two or more
counterparts, each of which, when executed, shall be deemed an original instrument.

IN WITNESS WHEREOF, Synovus has caused this Consulting Agreement to be executed on it behalf
and Yancey has hereunto set his hand and seal, as of the day and year first above written.

SYNOVUS FINANCIAL CORP.
 

	 	 	 	 	 
	 
	By:	 	/s/ G. Sanders Griffith, III
___________________________	 
	 
	
 	 	 	 
	 
	
Name: 	 	G. Sanders Griffith, III
___________________________	 
	 
	
 	 	 	 
	 
	Title:	 	Senior Executive Vice President	 

/s/James D. Yancey (L.S.)
____________________________
James D. Yancey

 

Exhibit A
SYNOVUS FINANCIAL CORP.

Personal Use of Company Aircraft

Key Executives are each allowed a maximum number of hours of personal use of company aircraft each
calendar year (Attachment 1).

Personal use of company aircraft by Key Executives includes non-business flights upon which the Key
Executive and his or her non-business guests are the only passengers aboard the aircraft and also
includes non-business flights upon which the Key Executive is not aboard the aircraft but his or
her non-business guests are the only passengers aboard the aircraft.

Personal use of company aircraft is calculated using “block hours,” as opposed to “flight hours,”
and includes “deadhead legs.”

For purposes of calculating the number of hours of personal use of company aircraft, each block
hour of turbo-prop usage shall equal “one hour of personal usage” and each block hour of jet usage
shall equal “two hours of personal usage.” Usage of less than whole hours shall be recorded
proportionately.

Personal use of company aircraft by Key Executives and their non-business guests is tracked and the
value reported for tax purposes for the Key Executive using the Standard Industry Fare Level (SIFL)
guidelines.

Bereavement and Medical Emergency Use of Company Aircraft

Other company team members may utilize a company aircraft for bereavement or medical emergency
purposes. All trips for this purpose shall be authorized by Sanders Griffith.

Use of Company Aircraft by Key Executives and Other Company

Executives on Previously Scheduled Business Flights

Key Executives and other company executives, and their respective non-business guests, may occupy
otherwise unoccupied seats on previously scheduled business flights of company aircraft, and, in
the case of Key Executives, such occupancy shall not be counted against the number of hours of
personal use of company aircraft available to them. All trips for this purpose shall be authorized
by Sanders Griffith. The travel of such executive and his or her non-business guests will be
tracked and the value reported for tax purposes to the executive using the SIFL guidelines.

1

Attachment 1

The following Executives are designated as eligible for the indicated number of hours of personal
use of company aircraft:

Synovus

Jim Blanchard—Synovus CEO—50 hours

Jimmy Yancey—Synovus COB—20 hours

Richard Anthony—Synovus President and COO-20 hours

Sonny Deriso—Synovus Vice Chairman—20 hours

Lee Lee James—Synovus Vice Chairman—20 hours

Fred Green—Synovus Vice Chairman—20 hours

Sanders Griffith—Synovus General Counsel—20 hours

TSYS

Phil Tomlinson—TSYS CEO—20 hours

Rick Ussery—TSYS COB—20 hours

Troy Woods—TSYS President and COO—20 hours

2Form of Directors' Restricted Stock Award

 

 

RESTRICTED STOCK AWARD

PURSUANT TO THE OMEGA HEALTHCARE INVESTORS, INC.

2004 STOCK INCENTIVE PLAN

THIS AWARD is made as of the Grant Date, by Omega Healthcare Investors, Inc. (the "Company") to ___________________________ (the "Recipient").

Upon and subject to the Terms and Conditions attached hereto and incorporated herein by reference as part of this Award, the Company hereby awards as of the Grant Date to the Recipient the Restricted Shares (the "Restricted Stock Grant"). 

	 	A.	Grant Date: .

	 	B.	Plan: (under which Restricted Stock Grant is granted): Omega Healthcare Investors, Inc. 2004 Stock Incentive Plan.

	 	C.	Restricted Shares: ________ shares of the Company’s common stock ("Common Stock"), subject to adjustment as provided in the attached Terms and Conditions.

	 	D.	Vesting Schedule: The Restricted Shares shall vest according to the Vesting Schedule attached hereto as Exhibit 1 (the "Vesting Schedule"). The Restricted Shares which have become vested pursuant to the Vesting Schedule are herein referred to as the "Vested Restricted Shares." 

IN WITNESS WHEREOF, the Company has executed this Award as of the Grant Date set forth above.

OMEGA HEALTHCARE INVESTORS, INC.

By:                         

Title:                         

	 
 

	 	 	 
	

	 

TERMS AND CONDITIONS TO THE

RESTRICTED STOCK AGREEMENT

PURSUANT TO THE OMEGA HEALTHCARE INVESTORS, INC.

2004 STOCK INCENTIVE PLAN

1.    Restricted Shares Held by the Share Custodian. The Recipient hereby authorizes and directs the Company to deliver any share certificate issued by the Company to evidence Restricted Shares to the Secretary of the Company or such other officer of the Company as may be designated by the Compensation Committee (the "Share Custodian") to be held by the Share Custodian until the Restricted Shares become Vested Restricted Shares in accordance with the Vesting Schedule. When the Restricted Shares become Vested Restricted Shares, the Share Custodian shall deliver the Restricted Shares to the Recipient. In the event that the Recipient forfeits any of the Restricted Shares, and the number of Vested Restricted Shares includes a fraction of a share, the Share Custodian shall not be required to deliver the fractional share, and the Company may pay the Recipient the amount determined by the Company to be the estimated fair market value therefor. The Recipient hereby irrevocably appoints the Share Custodian, and any successor thereto, as the true and lawful attorney-in-fact of the Recipient with full power and authority to execute any stock transfer power or other instrument necessary to transfer the Restricted Shares to the Company in accordance with this Award, in the name, place, and stead of the Recipient. The term of such appointment shall commence on the date of the Restricted Stock Grant and shall continue until the Restricted Shares are delivered to the Recipient as provided above. In the event the number of shares of Common Stock is increased or reduced by a change in the par value, split-up, stock split, reverse stock split, reclassification, merger, reorganization, consolidation, or otherwise, the Recipient agrees that any certificate representing shares of Common Stock or other securities of the Company issued as a result of any of the foregoing shall be delivered to the Share Custodian and shall be subject to all of the provisions of this Award as if initially granted thereunder. To effect the provisions of this Section, the Recipient shall complete an irrevocable stock power in favor of the Share Custodian in the form attached hereto as Exhibit 2.

2.    Rights of a Shareholder. During the period that the Share Custodian holds the shares of Common Stock subject to Section 1, the Recipient shall be entitled to all rights applicable to shares of Common Stock not so held, except as otherwise provided in the Award, including the right to receive dividends paid on Common Stock notwithstanding that all or some of the Restricted Shares may not be Vested Restricted Shares.     

3.     Withholding. This Section shall not apply if the Recipient is not and has not been an employee of the Company or an Affiliate. To the extent required by law, the Company shall have the right to require the Recipient to remit to the Company an amount sufficient to satisfy any federal, state and local withholding tax requirement, if any, upon the earlier of the vesting of the Restricted Shares or the effective date of an election pursuant to Section 83(b) of the Internal Revenue Code with respect to such Restricted Shares. The Recipient must pay the withholding tax (i) in cash; (ii) by certified check; or (iii) by tendering shares of Common Stock which have been owned by the Recipient for at least six (6) months prior to the date of exercise having a Fair Market Value equal to the withholding obligation.

4.    Restrictions on Transfer of Restricted Shares. Except for the transfer of any Restricted Shares by bequest or inheritance, the Recipient shall not have the right to make or permit to exist any transfer or hypothecation, whether outright or as security, with or without consideration, voluntary or involuntary, of all or any part of any right, title or interest in or to any unvested Restricted Shares. Any such disposition not made in accordance with this Award shall be deemed null and void. Any permitted transferee under this Section shall be bound by the terms of this Award.

5.    Additional Restrictions on Transfer.

Certificates evidencing the Restricted Shares shall have noted conspicuously on the certificate a legend required under applicable securities laws or otherwise determined by the Company to be appropriate, such as:

TRANSFER IS RESTRICTED

THE SECURITIES EVIDENCED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND FORFEITURE PROVISIONS WHICH ALSO APPLY TO THE TRANSFEREE AS SET FORTH IN A RESTRICTED STOCK AGREEMENT DATED        , A COPY OF WHICH IS AVAILABLE FROM THE COMPANY. THE SECURITIES EVIDENCED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, OR HYPOTHECATED UNLESS (1) THERE IS AN EFFECTIVE REGISTRATION UNDER SUCH ACT COVERING SUCH SECURITIES, (2) THE TRANSFER IS MADE IN COMPLIANCE WITH RULE 144 PROMULGATED UNDER SUCH ACT, OR (3) THE ISSUER RECEIVES AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT.

6.    Change in Capitalization.

(a)    The number and kind of unvested Restricted Shares shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a subdivision or combination of shares or the payment of a stock dividend in shares of Common Stock to holders of outstanding shares of Common Stock or any other increase or decrease in the number of shares of Common Stock outstanding is effected without receipt of consideration by the Company. No fractional shares shall be issued in making such adjustment. 

(b)    In the event of a merger, consolidation, extraordinary dividend, spin-off, sale of substantially all of the Company’s assets or other material change in the capital structure of the Company, or a tender offer for shares of Common Stock, or other reorganization of the Company, in each case that does not result in a Change in Control, the Compensation Committee shall take such action to make such adjustments with respect to the unvested Restricted Shares, in its sole discretion, determines in good faith is necessary or appropriate, including, without limitation, adjusting the number and class of securities subject to the unvested portion of the Award, substituting cash, other securities, or other property to replace the unvested portion of the Award, or removing of restrictions on unvested Restricted Shares. 

(c)    All determinations and adjustments made by the Compensation Committee pursuant to this Section will be final and binding on the Recipient. Any action taken by the Compensation Committee need not treat all recipients of awards under the Plan equally.

(d)    The existence of the Plan and the Restricted Stock Grant shall not affect the right or power of the Company to make or authorize any adjustment, reclassification, reorganization or other change in its capital or business structure, any merger or consolidation of the Company, any issue of debt or equity securities having preferences or priorities as to the Common Stock or the rights thereof, the dissolution or liquidation of the Company, any sale or transfer of all or part of its business or assets, or any other corporate act or proceeding.

7.    Governing Laws. This Award shall be construed, administered and enforced according to the laws of the State of Maryland; provided, however, no Restricted Shares shall be issued except, in the reasonable judgment of the Compensation Committee, in compliance with exemptions under applicable state securities laws of the state in which Recipient resides, and/or any other applicable securities laws.

8.    Successors. This Award shall be binding upon and inure to the benefit of the heirs, legal representatives, successors, and permitted assigns of the parties.

9.    Notice. Except as otherwise specified herein, all notices and other communications under this Award shall be in writing and shall be deemed to have been given if personally delivered or if sent by registered or certified United States mail, return receipt requested, postage prepaid, addressed to the proposed recipient at the last known address of the recipient. Any party may designate any other address to which notices shall be sent by giving notice of the address to the other parties in the same manner as provided herein.

10.    Severability. In the event that any one or more of the provisions or portion thereof contained in this Award shall for any reason be held to be invalid, illegal, or unenforceable in any respect, the same shall not invalidate or otherwise affect any other provisions of this Award, and this Award shall be construed as if the invalid, illegal or unenforceable provision or portion thereof had never been contained herein.

11.    Entire Agreement. Subject to the terms and conditions of the Plan, this Award expresses the entire understanding and agreement of the parties with respect to the subject matter. 

12.    Headings and Capitalized Terms. Paragraph headings used herein are for convenience of reference only and shall not be considered in construing this Award. Capitalized terms used, but not defined, in this Award shall be given the meaning ascribed to them in the Plan.

13.    Specific Performance. In the event of any actual or threatened default in, or breach of, any of the terms, conditions and provisions of this Award, the party or parties who are thereby aggrieved shall have the right to specific performance and injunction in addition to any and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative.

14.    No Right to Continued Retention. Neither the establishment of the Plan nor the award of Restricted Shares hereunder shall be construed as giving Recipient the right to continued service with the Company or an Affiliate.

 

	

	 	 	 
	

	 

Exhibit 1 to Restricted Stock Agreement

Vesting Schedule 

The Restricted Shares shall become vested as follows:

Percentage of                

Vested Restricted Shares              Vesting Date  

            33-1/3%                                  January 1, 20___

            66-2/3%                                     January 1, 20___

                       100%                        January 1, 20___

For purposes of the above schedule, the Restricted Shares shall become vested as indicated in the above schedule on each Vesting Date if the Recipient remains at all times a director, employee, or consultant of the Company or an Affiliate from the Grant Date to such Vesting Date. Any of the Restricted Shares which are not vested (1) at the time that the Recipient ceases to be a director, employee, or consultant of the Company due to death or Disability, or (2) upon a Change in Control shall become fully vested. Notwithstanding the foregoing, any of the Restricted Shares which are not vested at the time that the Recipient ceases to be a director, employee, or consultant of the Company or an Affiliate for any reason other than death or Disability shall be forfeited to the Company. 

For purposes of the above schedule, "Change in Control" means any one of the following events which occurs following the Grant Date:

(a)    the acquisition, directly or indirectly, by any "person" or "persons" (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), other than the Company or any employee benefit plan of the Company or an Affiliate, or any corporation pursuant to a reorganization, merger or consolidation, of equity securities of the Company, resulting in such person or persons holding equity securities of the Company that in the aggregate represent thirty percent (30%) or more of the combined ordinary voting power of the Company’s then outstanding equity securities; 

 

(b)    individuals who as of the date hereof, constitute the Board of Directors (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board of Directors; provided, however, that any individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least two-thirds of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors; 

(c)    a reorganization, merger or consolidation, with respect to which persons who were the holders of equity securities of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own equity securities of the surviving entity representing more than fifty percent (50%) of the combined ordinary voting power of the then outstanding voting securities of the surviving entity; or

(d)    a sale, or one or more sales occurring in a twelve-month period, of all or substantially all of the assets of the Company to any third party.

Notwithstanding the foregoing, no Change in Control shall be deemed to have occurred for purposes of this Award by reason of any actions or events in which the Recipient participates in a capacity other than in his capacity as an officer, employee, or director of the Company or an Affiliate. 

::ODMA\PCDOCS\ATL\838443\1

	
	 	 	 
	

	 

Exhibit 2 to Restricted Stock Agreement

Irrevocable Stock Power

The undersigned hereby assigns and transfers to Omega Healthcare Investors, Inc. (the "Company"), 1,000 shares of the Common Stock of the Company registered in the name of the undersigned on the stock transfer records of the Company and represented by Stock Certificate No. ____________________ of the Company; and the undersigned does hereby irrevocably constitute and appoint Thomas H. Peterson, his attorney-in-fact, to transfer the aforesaid shares on the books of the Company, with full power of substitution; and the undersigned does hereby ratify and confirm all that said attorney-in-fact lawfully shall do by virtue hereof.

Date:                      Signed:                  

 

                                                Print Name:                     

IN THE PRESENCE OF:

 

(Print Name)

 

 

(Signature)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]